Mitochondrial Injury and NASH

Fatty Liver Disease: NASH and Related Disorders

Volumn , Issue , 2007, Pages 132-142

  Fromenty, Bernard ^a   Pessayre, Dominique ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Lipid peroxidation; Nonalcoholic steatohepatitis (NASH); Phospholipids; Respiratory chain; Tumour necrosis factor? (TNF ?)

Indexed keywords

EID: 18844404493     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987438.ch11     Document Type: Chapter

References (46)

1. Pessayre D, Berson A, Fromenty B, Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis 2001; 21: 57-69.
2. Pessayre D, Mansouri A, Fromenty B. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2002; 282: G193-9.
3. Pessayre D. Mitochondrial injury in steatohepatitis. In: Suchy FJ, Gregory FJ, Maher JJ. American Association for the Study of Liver Diseases Postgraduate Course 2002. Mechanisms of Acute and Chronic Liver Diseases: Implications for Diagnosis, Pathogenesis and Treatment. AASLD Postgraduate Course, 2002: 97-103.
4. Tran K, Thorne-Tjomsland G, DeLong CJ et al. Intracellular assembly of very-low-density lipoproteins containing apolipoprotein B100 in rat hepatoma McA- RH777 cells. J Biol Chem 2002; 277: 31187-200.
5. Liao W, Yeung SCJ, Chan L. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full- length apolipoprotein B after translocation into the endoplamic reticulum. J Biol Chem 1998; 273: 27225-30.
6. McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Ann Rev Biochem 1980; 49: 395-420.
7. Fromenty B, Pessayre D. Inhibition of mitochondrial p- oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995; 67: 101-54.
8. Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635-43.
9. Shepherd PR, Kahn BB. Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341: 248-57.
10. Hirosumi J, Tuncman G, Chang L et al. A central role for JNK in obesity and insulin resistance. Nature 2002; 420: 353-6.
11. Chitturi S, Abeygunasekera S, Farrell GC et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance. Hepatology 2002; 35: 373-9.
12. Valet P, Tavernier G, Castan-Laurell I et al. Understanding adipose tissue development from transgenic animal models. J Lipid Res 2002; 43: 835-60.
13. Gorden ES. Non-esterified fatty acids in blood of obese and lean subjects. Am J Clin Nutr 1960; 8: 740-7.
14. Shimomura I, Bashmakov Y, Horton JD. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 1999; 274: 30028-32.
15. Sanyal AJ, Campbell-Sargent C, Mirshahi F et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-92.
16. Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair S. Apolipoprotein synthesis in non-alcoholic steatohepatitis. Hepatology 2002; 35: 898-904.
17. Bartels ED, Lauritsen M, Nielsen LB. Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice. Diabetes 2002; 51: 1233-9.
18. Lin MCM, Gordon DC, Wettereau JR. Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J Lipid Res 1995; 36: 1073-81.
19. Navasa M, Gordon DA, Hariharan N et al. Regulation of microsomal triglyceride transfer protein mRNA expression by endotoxin and cytokines. J Lipid Res 1998; 39: 1220-30.
20. Day CP, Saksena S, Leathart J et al. Genetic evidence supporting the two-hit model of NASH pathogenesis. Hepatology 2002; 36: 82A.
21. Kono H, Rusyn I, Yin M et al. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest 2000; 106: 867-72.
22. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with non-alcoholic steatohepatitis. Hepatology 1998; 27: 128-33.
23. Fiorini RN, Shafizadeh SF, Chavin KD. Primary nonfunction in steatotic livers is due to differential Toll-like expression and endotoxin sensitivity. Hepatology 2002; 36: 198A.
24. Enomoto N, Takei Y, Hirose M et al. Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-a production. Gastroenterology 2002; 123: 291-300.
25. Letteron P, Fromenty B, Terris B, Degott C, Pessayre D. Acute and chronic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol 1996; 24: 200-8.
26. Leclercq IA, Farrell GC, Field J et al. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine non-alcoholic steatohepatitis. J Clin Invest 2001; 105: 1067-75.
27. Hruszkewycz AM. Evidence for mitochondrial DNA damage by lipid peroxidation. Biochem Biophys Res Commun 1988; 153: 191-7.
28. Chen J, Schenker S, Frosto TA, Hensderson GI. Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE): role of HNE adduct formation with the enzyme catalytic site. Biochem Biophys Acta 1998; 1380: 336-44.
29. Haque M, Mirshahi F, Campbell-Sargent C et al. Nonalcoholic steatohepatitis (NASH) is associated with hepa- tocyte mitochondrial DNA depletion. Hepatology 2002; 36: 403A.
30. Perez-Carrera M, Del Hoyo P, Martin M et al. Activity of the mitochondrial respiratory chain enzymes is decreased in the liver of patients with non-alcoholic steatohepatitis. Hepatology 1999; 30: 379A.
31. Cortez-Pinto H, Chatham J, Chacko VP et al. Alterations in liver ATP homeostasis in human non-alcoholic steatohepatitis: a pilot study. J Am Med Assoc 1999; 282: 1659-64.
32. Yang SQ, Zhu H, Li Y et al. Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys 2000; 378: 259-68.
33. Hensley K, Kotake Y, Sang H et al. Dietary choline restriction causes complex I dysfunction and increased H2O2 generation in liver mitochondria. Carcinogenesis 2000; 21: 983-9.
34. Yin M, Gäbele E, Wheeler MD et al. Alcohol-induced free radicals in mice: direct toxicants or signaling molecules? Hepatology 2001; 34: 935-42.
35. Strauss RS. Comparison of serum concentrations of a- tocopherol and β-carotene in a cross-sectional sample of obese and non-obese children (NHANES III). J Pediatr 1999; 134: 160-5.
36. Lavine JE. Vitamin E treatment of non-alcoholic steato- hepatitis in children: a pilot study. J Pediatr 2000; 136: 739-43.
37. Berson A, De Beco V, Leteron P et al. Steatohepatitis- inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 1998; 114: 764-74.
38. Pessayre D, Feldmann G, Haouzi D et al. Hepatocyte apoptosis triggered by natural substances (cytokines, other endogenous substances and foreign toxins). In:Cameron RG, Feuer G, eds. Apoptosis and its Modulation by Drugs: Handbook of Experimental Pharmacology. Heidelberg: Springer Verlag, 2000, 142: 59-108.
39. Crespo J, Cayon A, Fernadez-Gil P et al. Gene expression of tumor necrosis factor-a and TNF-receptors p55 and p75 in non-alcoholic steatohepatitis patients. Hepatology 2001; 34: 1158-63.
40. Feldmann G, Haouzi D, Moreau A et al. Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in Fas-mediated hepatic apoptosis in mice. Hepatology 2000; 31: 674-83.
41. Natori S, Rust C, Stadheim LM et al. Hepatocyte apop- tosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 2001; 34: 248-53.
42. Rodriguez CM, Cortez-Pinto H, Sola S et al. Apoptosis is a prominent feature of human alcoholic and non-alcoholic steatohepatitis. Hepatology 2001; 34: 672A.
43. Sutton A, Khoury H, Prip-Buus C et al. The Ala-9Val dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003; 13: 145-57.
44. Stewart SF, Leathart JB, Chen Y et al. Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis. Hepatology 2002; 36: 1355-60.
45. Pessayre D, Dolder A, Artigou JY et al. Effect of fasting on metabolite-mediated hepatotoxicity in the rat. Gastroenterology 1979; 77: 264-71.
46. Haouzi D, Lekehal M, Tinel M et al. Prolonged, but not acute, glutathione depletion promotes Fas-mediated mitochondrial permeability transition and apoptosis in mice. Hepatology 2001; 33: 1181-8.